Evidence map›Paper›PMID 41474841›Full record

Observational studyJMIR formative research2025

Health Care Utilization in Patients With Atopic Dermatitis Experiencing Topical Steroid Withdrawal: Observational Cross-Sectional Social Media Questionnaire Study.

Alexander Shayesteh, Maja Af Klinteberg, Sophie Vrang, Gunnthorunn Sigurdardottir, MariHelen Sandström Falk, Mikael Alsterholm

Abstract readObservational Study
In one paragraph

Observational study in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander ShayestehDepartment of Public Health and Clinical Medicine, Dermatology and Venereology, Umeå University, Umeå, Sweden.ORCID 0000-0003-0700-7195
Maja Af KlintebergDepartment of Public Health and Clinical Medicine, Dermatology and Venereology, Umeå University, Umeå, Sweden.ORCID 0000-0002-9976-5702
Sophie VrangSwedish Asthma and Allergy Association, Stockholm, Sweden.ORCID 0009-0009-9330-8592
Gunnthorunn SigurdardottirDepartment of Dermatology and Venereology in Östergötland, Linköping University, Linköping, Sweden.ORCID 0000-0001-8617-9037
MariHelen Sandström FalkVasakliniken Dermatology Clinic, Gothenburg, Sweden.ORCID 0009-0007-7155-3613
Mikael AlsterholmDepartment of Dermatology and Venereology, Sahlgrenska Academy, Institute of Clinical Sciences, University of Gothenburg, Gröna stråket 16, Gothenburg, 41345, Sweden, 46 31-342-1000.ORCID 0000-0003-0523-7763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Topical steroid withdrawal (TSW) is a controversial skin condition among health care providers due to a lack of evidence, but it has an impactful and growing presence on social media. There are few previous reports of health care utilization for symptoms attributed to TSW. Objective: This study aims to investigate health care utilization and requests as well as information sources for TSW among patients with atopic dermatitis (AD). Methods: This observational cross-sectional study used a questionnaire aimed at adults with AD, experiencing symptoms they attribute to TSW. The questionnaire was posted as a link, free to share with others, in a Swedish TSW-themed Facebook group and remained accessible for 4 weeks. Descriptive statistics and topical text analysis on open-ended items were used to present and interpret the results. Results: The participants (n=82) reported dermatologists (n=41, 50%), general practitioners (n=40, 49%), and practitioners of complementary and alternative medicine (CAM; n=32, 39%) as the most frequent health care contacts for TSW. However, among participants with ongoing symptoms attributed to TSW (n=68), ongoing health care contacts with general practitioners, dermatologists, and practitioners of CAM were reported by only 10% (n=7), 22% (n=15), and 13% (n=11), respectively. For symptoms attributed to AD, the frequencies of health care provider contacts were higher. Almost all participants had sought help from a general practitioner (n=81, 99%) or a dermatologist (n=76, 93%) at some point, and many had also consulted a practitioner of CAM (n=59, 72%). Among those with ongoing symptoms attributed to AD, 43% (n=26) had an ongoing contact with a dermatologist. Participant-requested help and support from health care providers included understanding and confirmation of TSW impairments (n=45, 56%), treatment of symptoms (n=26, 32%), and increased awareness and information about TSW from health care providers (n=21, 26%). The most common TSW information sources were Facebook (n=78, 96%), websites (n=75, 93%), and Instagram (n=45, 56%), but YouTube (n=11, 14%), podcasts (n=7, 10%), and TikTok (n=5, 6%) were also reported. Conclusions: This study investigates health care utilization patterns related to TSW. The results indicate that the participants received insufficient support from health care providers for symptoms they attributed to TSW. The participants initiated and maintained health care provider contacts for symptoms attributed to AD to a greater extent than for TSW and sought information and support for TSW elsewhere. Targeted interventions to overcome this could be educational efforts for general practitioners and dermatologists about the current scientific knowledge of TSW as well as the TSW discourse on social media. In addition, health care providers need to engage and contribute to evidence-based content about TSW on relevant social media platforms to prevent the spread of misinformation about topical glucocorticoids.

Indexed as

Dermatitis, AtopicPatient Acceptance of Health CareSocial MediaSteroidsSubstance Withdrawal SyndromeAdministration, TopicalAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesSwedenSteroidsatopic dermatitisred skin syndrometopical steroid addictiontopical steroid withdrawaltopical steroid withdrawal syndrome

Identifiers

PMID41474841
PMCPMC12755344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.